RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How To Budget For Site Payments Success
Unearth how bringing the functions of medical writing, clinical data management, and electronic data capture can positively impact the creation of a budget and payment process.
-
Improving Patient Outcomes With Wearables In Major Depressive Disorder
Learn how medical-grade wearable devices can help advance treatments in conditions like major depressive disorder and paint a more complete picture of patients with this often debilitating condition.
-
How EDC Software Minimizes Bias In Clinical Trials
Electronic Data Capture (EDC) systems play a crucial role in mitigating bias through automated validation rules, structured workflows, and real-time monitoring.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies
Real-world data (RWD) is transforming colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.
-
Balancing Clinical Care With Digital Utility In Hybrid Trials
To create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.
-
Navigating eCOA Licensing And Localization In Clinical Trials
eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.
-
4 Key eCOA Benefits To Speed Up Your Clinical Trial
As the healthcare landscape moves towards a patient-centric approach, explore how sponsors and regulatory bodies look to eCOAs more and more for obtaining patient data.
-
Top HEOR Trends
Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.
-
How A Dedicated Medical Affairs Team Drives Site Engagement
See how improvements made to SIP have allowed for quick access to study documents and bulk actions for streamlined document management and enhanced user experience.
RECENT NEWSLETTERS
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials